AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Cash Flow PerformanceNormalizing
Percentile Rank79
3Y CAGR-20.5%
5Y CAGR-24.7%
Studio
Year-over-Year Change

Free cash flow yield

3Y CAGR
-20.5%/yr
vs +48.2%/yr prior
5Y CAGR
-24.7%/yr
Recent acceleration
Acceleration
-68.7pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20252.96%+271.3%
2024-1.73%-57.2%
2023-1.10%-118.6%
20225.90%+109.4%
20212.82%-76.9%
202012.19%+6058.3%
20190.20%-83.8%
20181.22%-69.5%
20174.01%+1296.1%
2016-0.34%-